Cocrystal engineering of pharmaceutical solids: Therapeutic potential and challenges

SN Wong, YCS Chen, B Xuan, CC Sun, SF Chow - CrystEngComm, 2021 - pubs.rsc.org
Cocrystals are an emerging class of crystalline materials composed of two or more different
molecules in the same crystal lattice that are physically connected by non-ionic and non …

Co-crystallization approach to enhance the stability of moisture-sensitive drugs

MR Dhondale, P Thakor, AG Nambiar, M Singh… - Pharmaceutics, 2023 - mdpi.com
Stability is an essential quality attribute of any pharmaceutical formulation. Poor stability can
change the color and physical appearance of a drug, directly impacting the patient's …

Pharmaceutical cocrystals: molecules, crystals, formulations, medicines

MAE Yousef, VR Vangala - Crystal Growth & Design, 2019 - ACS Publications
Cocrystals are long known yet recently applied molecular entities. In the past decade, a
significant potential has been demonstrated by these novel solids in terms of modifying the …

Crystalline multicomponent solids: An alternative for addressing the hygroscopicity issue in pharmaceutical materials

TS Thakur, R Thakuria - Crystal Growth & Design, 2020 - ACS Publications
The ambient humidity varies with seasons and geographical altitude across the regions. A
change in relative humidity during processing, storage, and transportation can cause …

Effects of additives on the physical stability and dissolution of polymeric amorphous solid dispersions: A review

J Li, Y Wang, D Yu - AAPS PharmSciTech, 2023 - Springer
Polymeric amorphous solid dispersion (ASD) is a popular approach for enhancing the
solubility of poorly water-soluble drugs. However, achieving both physical stability and …

Cocrystals of favipiravir: improved physicochemical properties and solution stability study

H Li, L Wang, G Xie, C Yao, S Song, Y Qu… - Crystal Growth & …, 2023 - ACS Publications
Favipiravir (FPV) is used in the treatment of viral influenza, but it faces challenges due to its
moderate solubility and poor tabletability. As an oral drug, it is necessary to develop a drug …

Investigating the role of the reduced solubility of the pirfenidone–fumaric acid cocrystal in sustaining the release rate from its tablet dosage form by conducting …

N Kumari, P Roy, S Roy, PK Parmar… - Molecular …, 2022 - ACS Publications
Pirfenidone (PFD) is the first pharmacological agent approved by the US Food and Drug
Administration (FDA) in 2014 for the treatment of idiopathic pulmonary fibrosis (IPF). The …

Pharmaceutical cocrystals: formulation approaches to develop robust drug products

NK Duggirala, SM LaCasse, MJ Zaworotko… - Crystal Growth & …, 2019 - ACS Publications
Phase transformation of an active pharmaceutical ingredient in the solid state can influence
the physicochemical properties and consequently drug product performance. The neat …

Role of coformer and excipient properties on the solid-state stability of theophylline cocrystals

S Koranne, JF Krzyzaniak, S Luthra… - Crystal Growth & …, 2019 - ACS Publications
The stability of theophylline cocrystals composed of acidic (glutaric acid), basic
(isonicotinamide), or neutral (benzamide) coformers was evaluated in the presence of …

In situ monitoring of the crystalline state of active pharmaceutical ingredients during high-shear wet granulation using a low-frequency Raman probe

K Nomura, V Titapiwatanakun, H Hisada… - European Journal of …, 2020 - Elsevier
Optimization of manufacturing processes based on scientific evidence is important in the
quality control of active pharmaceutical ingredients (APIs) and drug products, particularly …